JAKARTA. PT Hermina Medikaloka Tbk (HEAL), the managing company of the Hermina Hospital netwok, will issue Shelf-Registration Bonds I Phase II Year 2022 with a principal of IDR 553.5 billion.
This round of issuance is a part of a more extensive public offering program of Shelf-Registration Bonds I of HEAL, which eyes IDR 1 trillion of returns. Back in 2020, the company had issued the first phase of bonds issuance worth IDR 446.5 billion.
In this second phase, HEAL will guarantee the bonds of a principal value of IDR 100 billion with a full commitment. The remaining amount will be guaranteed with the best effort.
HEAL will allocate 40% of the bonds issuance proceeds to increase the capacity of the hospital, as stated in the official release. Then, another 25% will be spent on acquiring general and medical equipment, leaving the remaining portion to the working capital of the company and its subsdiaries.
The public offering period of HEAL will take place on July 8 and 11, 2022. The electronic distribution of these bonds will follow on July 14, 2022, before being concluded through the listing on Indonesia Stock Exchange (IDX) on July 15, 2022.
HEAL has appointed PT DBS Vickers Sekuritas Indonesia, PT Mandiri Sekuritas, and PT Maybank Sekuritas Indonesia as the underwriters. Meanwhile, PT Bank Rakyat Indonesia (Persero) Tbk (BBRI) will act as the trustee. (KR/ZH)